Form 13G MediWound Ltd. For: 5 February
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mediwound Ltd (MDWD)
Mediwound Ltd stock price live, this page displays NASDAQ MDWD stock exchange data. View the MDWD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mediwound Ltd real time stock price chart below.
What Is the Mediwound Ltd Stock Price Today?
The Mediwound Ltd stock price today is 17.790.
What Is the Stock Symbol for Mediwound Ltd?
The stock symbol for Mediwound Ltd is "MDWD."
What Stock Exchange Does Mediwound Ltd Trade On?
Mediwound Ltd is listed and trades on the NASDAQ stock exchange.
Is Mediwound Ltd a Good Stock to Buy?
Determining whether Mediwound Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDWD quote. (ISIN: IL0011316309)
What Is the Mediwound Ltd Stock Price Today?
The Mediwound Ltd stock price today is 17.790.
What Is the Stock Symbol for Mediwound Ltd?
The stock symbol for Mediwound Ltd is "MDWD."
What Stock Exchange Does Mediwound Ltd Trade On?
Mediwound Ltd is listed and trades on the NASDAQ stock exchange.
Is Mediwound Ltd a Good Stock to Buy?
Determining whether Mediwound Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDWD quote. (ISIN: IL0011316309)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.360
17.900
52 wk Range
14.140
22.505
MDWD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.36017.900
52 wk Range
14.14022.505
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MDWD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
31.500
Upside
+77.07%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
- Form 144 MediWound Ltd. For: 3 December
- Investing.com
- Form 6K MediWound Ltd. For: 15 January
- Investing.com
- Form 13G MediWound Ltd. For: 5 February
- Investing.com
- Form 6K MediWound Ltd. For: 15 January
- Investing.com
- Form 6K Mediwound Ltd For: 12 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Mediwound Ltd Company Profile
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Mediwound Ltd Earnings Call Summary for Q4/2024
- Q4 2024 EPS of -$0.36 beat expectations; revenue reached $5.84M, slightly above forecast
- Full-year 2024 revenue increased to $20.2M from $18.7M in 2023; net loss of $30.2M or $3.03 per share
- NexoBrid 2025 revenue projected at $24M; Phase 3 VLU Global Trial for EscharEx interim analysis expected mid-2026
- Stock closed at $19.19, down 0.42% pre-market despite earnings beat; analysts maintain bullish outlook
- Strong liquidity with current ratio of 2.11; cash position of $43.6M at year-end
Last Updated: 03/19/2025, 09:40 PM
Read Full TranscriptCompare MDWD to Peers and Sector
Metrics to compare | MDWD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMDWDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.1x | −1.3x | −0.5x | |
PEG Ratio | −0.31 | 0.19 | 0.00 | |
Price/Book | 4.5x | 2.6x | 2.6x | |
Price / LTM Sales | 10.9x | 1.7x | 3.3x | |
Upside (Analyst Target) | 81.6% | 125.5% | 45.7% | |
Fair Value Upside | Unlock | 18.5% | 6.5% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.500
(+77.07% Upside)
Earnings
Latest Release
Nov 20, 2025
EPS / Forecast
-0.24 / -0.81
Revenue / Forecast
5.43M / 6.56M
People Also Watch
FAQ
What Is the Mediwound (MDWD) Stock Price Today?
The Mediwound stock price today is 17.790
What Stock Exchange Does Mediwound Trade On?
Mediwound is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Mediwound?
The stock symbol for Mediwound is "MDWD."
What Is the Mediwound Market Cap?
As of today, Mediwound market cap is 228.09M.
What Is Mediwound's Earnings Per Share (TTM)?
The Mediwound EPS (TTM) is -1.90.
When Is the Next Mediwound Earnings Date?
Mediwound will release its next earnings report on Mar 11, 2026.
From a Technical Analysis Perspective, Is MDWD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Mediwound Stock Split?
Mediwound has split 1 times.
How Many Employees Does Mediwound Have?
Mediwound has 111 employees.
What is the current trading status of Mediwound (MDWD)?
As of Feb 07, 2026, Mediwound (MDWD) is trading at a price of 17.790, with a previous close of 17.220. The stock has fluctuated within a day range of 17.360 to 17.900, while its 52-week range spans from 14.140 to 22.505.
What Is Mediwound (MDWD) Price Target According to Analysts?
The average 12-month price target for Mediwound is USD31.500, with a high estimate of USD39 and a low estimate of USD25. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +77.07% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.